SUNIL AGARWAL
CIK 1616640 · EVP, Head of Development & CMO · last filed 2026-01-23
SUNIL AGARWAL is an EVP, Head of Development & CMO who has filed 53 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing, for ATXS, was dated Jan 23, 2026. Across all open-market trades the lifetime net is −$4.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.61M
7
53
-$4.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 3 | 2026-01-23 |
| ARVN | Director | 30,166 | $7.58 | $228.7K | $0 | 3 | 2025-06-30 |
| CALA | Director | — | $0.00 | — | $0 | 8 | 2022-06-03 |
| SANA | EVP, Head of Development & CMO | 1,551,627 | $2.68 | $4.16M | -$1.56M | 4 | 2022-03-08 |
| MyoKardia, Inc. (MYOK) Delisted | Director | 2,300 | — | — | $0 | 8 | 2020-06-23 |
| Juno Therapeutics, Inc. (JUNO) Delisted | President of R & D | 35,893 | — | — | -$326.1K | 5 | 2018-03-07 |
| RARE | Chief Medical Officer | 9,136 | $24.35 | $222.5K | -$2.39M | 21 | 2016-08-23 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-30 | ARVN | Grant (A) | +16,025 | $0 | EDGAR |
| 2025-06-12 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-31 | ARVN | Grant (A) | +5,899 | $0 | EDGAR |
| 2024-04-09 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | ARVN | Grant (A) | +8,242 | $0 | EDGAR |
| 2022-06-03 | CALA | Grant (A) | — | $0 | EDGAR |
| 2022-03-08 | SANA | Grant (A) | — | $0 | EDGAR |
| 2021-09-17 | SANA | Sell (S) | −60,000 | -$1.56M | EDGAR |
| 2021-06-14 | CALA | Grant (A) | — | $0 | EDGAR |